Atrial defibrillation thresholds of electrode configurations available to an atrioventricular defibrillator

Journal of Cardiovascular Electrophysiology

Volumn 12, Issue 8, 2001, Pages 957-964

  Benser, M E ^a   Walcott, G P ^a   Killingsworth, C R ^a   Girouard, S D ^a   Morris, M M ^a   Ideker, R E ^a  

^a BOSTON SCIENTIFIC CORPORATION   (United States)

Author keywords

Atrial cardioversion; Atrial defibrillation threshold; Atrioventricular defibrillator; Coronary sinus lead; Implantable cardioverter defibrillator

Indexed keywords

METHACHOLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATHETER; DEFIBRILLATION; DEFIBRILLATOR; ELECTRODE; HEART ATRIUM FIBRILLATION; NONHUMAN; PRIORITY JOURNAL; SHEEP;

EID: 0034882020     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8167.2001.00957.x     Document Type: Article

References (38)

1. Transthoracic cardioversion of atrial fibrillation and flutter: Standard techniques and new advances
2. Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation
3. The treatment of atrial fibrillation. An evaluation of drug therapy, electrical modalities and therapeutic considerations
4. Catheter ablation for atrial fibrillation
5. A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion
6. Atrioverter: An implantable device for the treatment of atrial fibrillation
7. Clinical experience with implantable atrial and combined atrioventricular defibrillators
8. Tolerability of internal low-energy shock strengths currently needed for endocardial atrial cardioversion
9. Atrial defibrillation: Are low energy shocks acceptable to patients?
10. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans
11. Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system
12. Internal cardioversion of atrial fibrillation in sheep
13. Internal cardioversion of atrial fibrillation: Marked reduction in defibrillation threshold with dual current pathways
14. Marked reduction in internal atrial defibrillation thresholds with dual-current pathways and sequential shocks in humans
15. Clinical efficacy and safety of atrial defibrillation using biphasic shocks and current nonthoracotomy endocardial lead configurations
16. Cardiac vein electrodes for transvenous atrial defibrillation
17. Right atrial electrode location for transvenous atrial defibrillation
18. The atrial defibrillator: A stand-alone device or part of a combined dual-chamber system?
19. Reduction of atrial defibrillation threshold with an interatrial septal electrode
20. The up-and-down method for small samples
21. Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart
22. Transvenous ICD leads for single and dual chamber ICDs: Actual and future developments
23. The atrial defibrillation threshold of CS - SVC+Can and RV+CS - SVC+Can are lower than that of RV - SVC+Can in humans
24. Suitability of a skin electrode for pre-implant testing of sequential pulse implantable defibrillator electrode systems
25. Atrial defibrillation with a transvenous lead: A randomized comparison of active can shocking pathways
26. Transvenous atrial cardioversion of atrial cardioversion threshold in patients with implantable cardioverter defibrillator: Influence of active pectoral can
27. Optimal defibrillation pathway for an implantable atrial defibrillator without a coronary sinus lead
28. Insights into lead configuration and initial atrial defibrillation thresholds in a dual chamber active can defibrillator
29. Implantable dual chamber defibrillators for atrial defibrillation
30. A randomized comparison of active pectoral lead configurations for atrial defibrillation
31. Effect of electrode configuration and capacitor size on internal atrial defibrillation threshold using leads currently used for ventricular defibrillation
32. Atrial defibrillation using a unipolar, single lead fight ventricular to pectoral can system
33. Is energy for transvenous defibrillation of atrial fibrillation (AF) with active pectoral cans feasible?
34. Patient discomfort after transvenous catheter cardioversion of atrial tachyarrhythmias with rounded waveforms: Initial results
35. Evaluation of two new biphasic waveforms for internal cardioversion of atrial fibrillation
36. Which patients do benefit from an implantable atrial defibrillator?
37. Effect of a passive endocardial electrode on defibrillation efficacy of a nonthoracotomy lead system
38. The ventricular defibrillation threshold of RV → CS+SVC+Can is lower than that of RV → SVC+Can